Table of Contents Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market Report 2012-2023 1 Xerostomia (Dry Mouth) Therapeutics Overview 1.1 Product Overview and Scope of Xerostomia (Dry Mouth) Therapeutics 1.2 Classification of Xerostomia (Dry Mouth) Therapeutics by Product Category 1.2.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Types in 2017 1.2.3 Salivary Stimulants 1.2.4 Salivary Substitutes 1.2.5 Dentifrices 1.3 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market by Application/End Users 1.3.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 OTC 1.3.3 Prescription 1.4 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market by Region 1.4.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 China Status and Prospect (2012-2023) 1.4.3 Japan Status and Prospect (2012-2023) 1.4.4 South Korea Status and Prospect (2012-2023) 1.4.5 Taiwan Status and Prospect (2012-2023) 1.4.6 India Status and Prospect (2012-2023) 1.4.7 Southeast Asia Status and Prospect (2012-2023) 1.4.8 Australia Status and Prospect (2012-2023) 1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of Xerostomia (Dry Mouth) Therapeutics (2012-2023) 1.5.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics 2.2 Raw Material Analysis of Xerostomia (Dry Mouth) Therapeutics 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of K Units 2.4 Other Costs Analysis of Xerostomia (Dry Mouth) Therapeutics 2.5 Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics 2.6 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics 2.7 Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2018 2.8 Downstream Buyers 3 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Players/Suppliers Profiles and Sales Data 3.1 GlaxoSmithKline plc 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 GlaxoSmithKline plc Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.2 Church & Dwight Co., Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Church & Dwight Co., Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.3 Colgate-Palmolive Company 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Colgate-Palmolive Company Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.4 Hikma Pharmaceuticals PLC 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Hikma Pharmaceuticals PLC Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.5 Pendopharm 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pendopharm Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.6 Sun Pharmaceuticals Industries Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sun Pharmaceuticals Industries Ltd. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.7 Lupin Pharmaceuticals, Inc. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Lupin Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.8 Pfizer, Inc. 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Pfizer, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.9 Parnell Pharmaceuticals, Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Parnell Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.10 Acacia Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Acacia Pharma Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.11 OraCoat 4 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Competition by Players/Manufacturers, Region, Type and Application 4.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market Competition by Players/Manufacturers 4.1.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales and Revenue by Type 4.2.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales and Revenue by Application 4.3.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Application 5 China Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 5.1 China Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 5.1.1 China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 5.1.2 China Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 5.1.3 China Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 5.2 China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 5.3 China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 6 Japan Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 6.1 Japan Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 6.1.1 Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Japan Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 6.1.3 Japan Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 6.2 Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 6.3 Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 7 South Korea Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 7.1 South Korea Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 7.1.1 South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Korea Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 7.1.3 South Korea Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 7.3 South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 8 Taiwan Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 8.1 Taiwan Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 8.1.1 Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Taiwan Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 8.1.3 Taiwan Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 8.2 Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 8.3 Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 9 India Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 9.1 India Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 9.1.1 India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 9.1.2 India Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 9.1.3 India Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 9.2 India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 9.3 India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 10 Southeast Asia Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 10.1 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 10.1.1 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 10.1.3 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 10.2 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 10.3 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 11 Australia Xerostomia (Dry Mouth) Therapeutics (Sales, Revenue and Price) 11.1 Australia Xerostomia (Dry Mouth) Therapeutics Sales and Value (2012-2017) 11.1.1 Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Australia Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) 11.1.3 Australia Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 11.2 Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Type 11.3 Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) 13.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) 13.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 China Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 Japan Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 South Korea Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Taiwan Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South Korea Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Australia Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2018-2023) 13.3.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2018-2023) 13.3.3 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Price Forecast by Type (2018-2023) 13.4 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023 Table Asia-Pacific Market Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Application (2016-2023) Figure Product Picture of Xerostomia (Dry Mouth) Therapeutics Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Types in 2017 Figure Salivary Stimulants Picture Figure Salivary Substitutes Picture Figure Dentifrices Picture Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Comparison by Applications (2012-2023) Figure Asia-Pacific Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Applications in 2017 Figure OTC Picture Figure Prescription Picture Table Asia-Pacific Market Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Figure China Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure South Korea Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure India Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Australia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Xerostomia (Dry Mouth) Therapeutics Table Industry News List of Xerostomia (Dry Mouth) Therapeutics Figure Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics in 2017 Figure Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics Table Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2017 Table Major Buyers of Xerostomia (Dry Mouth) Therapeutics Table GlaxoSmithKline plc Basic Information List Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Basic Information List Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Basic Information List Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Basic Information List Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Basic Information List Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Basic Information List Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Basic Information List Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Basic Information List Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Basic Information List Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Company Acacia Pharma Basic Information List Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales Asia-Pacific Market Share (%) (2012-2017) Figure Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Revenue Asia-Pacific Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Company Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Players/Manufacturers (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share (%) by Players/Manufacturers Figure 2017 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Share by Players/Manufacturers Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players Figure 2017 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Players Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share (%) by Type (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2012-2017) Figure Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (%) by Type (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Share by Regions (2012-2017) Figure Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Regions (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Regions in 2017 Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Xerostomia (Dry Mouth) Therapeutics by Regions (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Regions in 2017 Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Market Share by Application (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Share (%) by Application (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Japan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Japan Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure South Korea Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Korea Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure India Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure India Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Australia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Australia Xerostomia (Dry Mouth) Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Type (2012-2017) Table Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Type in 2017 Table Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) by Applications (2012-2017) Table Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Regions (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Market Share Forecast by Regions in 2023 Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Regions in 2023 Figure China Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure India Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Australia Xerostomia (Dry Mouth) Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Australia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Type (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Type (2018-2023) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Type (2018-2023) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales (K Units) Forecast by Application (2018-2023) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline plc Church & Dwight Co., Inc. Colgate-Palmolive Company Hikma Pharmaceuticals PLC Pendopharm Sun Pharmaceuticals Industries Ltd. Lupin Pharmaceuticals, Inc. Pfizer, Inc. Parnell Pharmaceuticals, Inc. Acacia Pharma OraCoat